Amaç: Bu çalışmada diyabetik ayaklı hastalarda ve yeni tanı konulmuş tip 2 diabetes mellitus (DM)'lu hastalarda osteoprotegerin (OPG) ve 25-hidroksi D vitamini (25(OH)D) düzeyleri karşılaştırıldı ve diyabetik ayaklı hastalarda 25(OH)D eksikliğinin yaygınlığı ve şiddeti araştırıldı.
Osteoprotegerin (OPG) is a glycoprotein which is a member of the tumor necrosis factor (TNF) family. Osteoprotegerin was first found in the bones. [1] It acts as a strong antiresorptive factor. Osteoprotegerins effect is demonstrated by binding or neutralizing the receptor activator nuclear factor kappa B ligand (RANKL). [2] Recent studies have shown that OPG is present in mesenchymal tissues and in vitro production of OPG is performed by vascular smooth muscle cells. [3, 4] Osteoprotegerin and RANKL are the two important regulators of mineral metabolism in both bone and vascular tissues. Also, OPG has been shown to be present in the arterial wall by both experimental and human studies. [5, 6] Peripheral artery disease (PAD) is the underlying predisposing factor in the etiology of the majority of diabetic feet. A strong relationship between serum OPG level and severity of PAD was reported in 67 patients by Ziegler et al. [7] Vitamin D plays a role in calcium and bone metabolism and it is known to be an important immune modulator agent. [8, 9] Receptors for activated vitamin D form on pancreatic beta cells and immunosuppressive cells have been described. [10, 11] Evidence for the relationship between vitamin D deficiency and bacterial and viral infections is also available. [12, 13] Vitamin D provides the death of macrophage-mediated bacteria and stimulates phagocytosis. Vitamin D deficiency poses a possible risk for diabetic foot infections in diabetic patients. [14] Therefore, in this study, we aimed to compare the levels of OPG and 25-hydroxy vitamin D (25(OH)D) in patients with diabetic foot and patients with newly diagnosed type 2 diabetes mellitus (DM) and to investigate the prevalence and severity of 25(OH)D insufficiency in patients with diabetic foot. [15] The diabetic foot group was selected from patients with PAD. Arterial Doppler ultrasonography was performed and diabetic feet with particularly neuropathic pain were not included. Diabetic foot group consisted of patients with biphasic, monophasic or non-flowable anterior dorsalis pedis and posterior tibial artery diabetic feet. Wound ulcers in patients with diabetic foot were classified according to Wagner's classification (Table I) : grade 1, n=6; grade 2, n=22; grade 3, n=19; grade 4, n=8; and grade 5, n=3.
PATIENTS AND METHODS
Serum concentration of 25(OH)D was determined by using electrochemiluminescence immunoassay utilized in fasting patients' morning blood samples. Serum concentration of OPG was determined by enzyme-linked immunosorbent assay (ELISA) (eBioscience kit, Bender Medsystems GmbH Campus Vienna Biocenter 2, Vienna, Austria) using the same blood samples. Blood samples were collected into yellow blood collection tubes, their serum was separated, and aliquots of 300 μL were stored frozen at -80°C until analysis. For OPG ELISA eBioscience kit, reference values for normal serum samples were 5-100 pg/mL.
Statistical analysis
IBM SPSS version 22.0 software (IBM Corp. Armonk, NY, USA) was used for statistical analyses. Mean, standard deviation, median lowest, highest, frequency and ratio values were used in the descriptive statistics of the data. Distribution of the variables was measured by the Kolmogorov-Smirnov test. Independent sample t-test and Mann-Whitney U test were used in the analysis of quantitative independent data while chi-square test was used in the analysis of qualitative independent data. Spearman correlation analysis was used for correlation analysis.
RESULTS
The age of the patients with diabetic foot was significantly higher than the control group (p>0.05). Gender distribution between diabetic foot patients and control group did not differ significantly (p<0.05) (Tables II and III) . The duration of diabetes in the diabetic foot group was significantly higher than the control group (p<0.05) (Tables II and III) . The 25(OH)D value in the diabetic foot group was significantly lower than the control group (p<0.05) (Tables II and III) ( Figure 1 ). Osteoprotegerin levels in diabetic foot group were significantly higher than the control group (p<0.05) (Tables II and III ) ( Figure 2 ). The hemoglobin A1c (HbA1c) value did not differ significantly between the diabetic foot and control groups (p>0.05) (Table II) . There was significant positive correlation between OPG level and CRP value (r=0.379, p<0.05) (Table IV) ( Figure 3 ). There was significant positive correlation between OPG level and creatinine value (r=0.562, p<0.05) (Table IV ) ( Figure 4 ).
DISCUSSION
Osteoprotegerin levels are positively associated with age, [16] diabetes, [17] renal insufficiency, [18] CRP, fibrinogen interleukin 6 (IL-6) and glycemic status. [19] [20] [21] It is also associated with cardiac mortality. [22, 23] Recent studies have reported that a high OPG level is an independent risk factor for progressive arteriosclerosis. [17] OPG is a new marker for PAD. [24] It is more cost-effective and less invasive than angiography, which has renal side effects. Rasmussen et al. [21] demonstrated that plasma OPG was higher in nephropathic type 1 diabetic patients than type 1 patients without nephropathy. Furthermore, a study of 46 predialysis patients with kidney failure demonstrated that OPG increased with decreased kidney function, as determined by creatinine clearance. The mentioned study showed the same association between glomerular filtration rate and OPG levels among patients with diabetic nephropathy. They also found significant correlations between plasma OPG levels and cardiovascular status. This correlation seemed relatively strong and independent of kidney function and was observed both in normoalbuminuric and nephropathic patients. Kim et al. [20] detected that serum OPG levels significantly correlate with fasting blood glucose, IL-6 and CRP levels.
In our study, OPG levels in patients with diabetic foot were significantly higher than the diabetic control group (Figure 2 , Table II ). Moreover, there was a positive correlation with CRP and creatinine values (Figures 3 and 4 , Table IV ). Osteoprotegerin levels were approximately 4-5 times higher in patients with diabetic foot in which CRP and creatinine levels were increased together. Creatinine levels probably increase when severity of necrosis and infections in diabetic feet increase, and OPG levels probably increase very seriously, as we have observed in our study. Very increased OPG may be indicative of severe endothelial damage in veins and increased cardiac mortality. [22, 23] Increased OPG levels in patients with diabetic foot may demonstrate existing vascular damage. Osteoprotegerin may also display the severity of the clinical status in these patients due to its positive correlation with CRP and creatinine (Table IV, Figures 3 and 4) .
In this study, we also investigated the 25(OH)D levels in diabetic feet. In the guideline for diagnosis and treatment of metabolic bone diseases published (Table V) .
We detected 25(OH)D deficiency or serious deficiency in the majority of our diabetic foot patients. The control group also had widespread 25(OH)D deficiency. However, when compared statistically, 25(OH)D levels in diabetic foot patients were significantly lower (Figure 1 ). We found that the average 25(OH)D level in patients with diabetic foot was 7.9 ng/mL (Tables II and III) . Tiwari et al. [25] have suggested that vitamin D deficiency escalated inflammatory cytokine release (IL-1b, IL-6, TNF-a) in patients with diabetic foot infection, particularly when its serum concentration was very low. Therefore, they suggest a 25(OH)D value <10 ng/mL (25 nmol/L) as the 'cut-off' for unfavorable immunological alterations in patients with diabetes mellitus. [25] It is shown that polymorphonuclear leukocytes and IL-1b regulation deteriorate in patients with diabetic foot infection. [26] Vitamin D suppresses T cell proliferation and decreases the production of the T helper type 1 cytokines while promoting the production of T helper type 2 cytokines. [27] T helper type 2 cells primarily play a role in response to extracellular pathogens. [14] Tiwari et al. [14] emphasized that in addition to hyperglycemia; vitamin D deficiency may lead to increased risk of infection in diabetic foot patients, as it causes a decrease in immunoreactive cells that respond to infection.
We observed clinically that diabetic foot infections healed after abscess drainage, glycemic control, antibiotic therapy and vitamin D supplementation. Diabetic foot develops in the later stages of diabetes in general. In our study, we also found that the average age and the duration of disease in diabetic foot patients were higher than the control group.
In conclusion, we demonstrated that OPG levels were increased in patients with diabetic foot. Elevated OPG levels in diabetic foot patients may indicate the severity of the clinical status due to its positive correlation with CRP, creatinine, vascular endothelial damage and glycemic status. However, future studies are required to provide additional information in this field. Vitamin D deficiency is commonly observed in diabetic foot patients. Thus, diabetic foot patients with 25(OH)D levels lower than 10 ng/mL should be supplemented with vitamin D to prevent unfavorable immunological alterations. 
